Odyssean LLC’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Odyssean LLC's TGTX Position: Q3 2026 in Review
Odyssean LLC increased its TG Therapeutics (TGTX) stake by 60% in Q3 2026, buying an estimated $1.03M and bringing the position to 50,732 shares worth $2.83M. The position accounts for 0.33% of the portfolio, ranked #136.
Odyssean LLC first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Odyssean LLC held 50,732 shares of TG Therapeutics worth $2.83M as of Q3 2026.
- Odyssean LLC bought 19,080 TG Therapeutics shares in Q3 2026, an estimated $1.03M.
- TG Therapeutics made up 0.33% of Odyssean LLC's portfolio in Q3 2026, its #136 holding.
- Odyssean LLC first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.